Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis

Sullivan, 2010, Evidence for self-renewing lung cancer stem cells and their implications in tumor initiation, progression, and targeted therapy, Cancer Metastasis Rev, 29, 61, 10.1007/s10555-010-9216-5 Pao, 2011, New driver mutations in non–small-cell lung cancer, Lancet Oncol, 12, 175, 10.1016/S1470-2045(10)70087-5 Paez, 2004, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science, 304, 1497, 10.1126/science.1099314 Pao, 2004, EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc Natl Acad Sci U S A, 101, 13306, 10.1073/pnas.0405220101 Mok, 2009, A small step towards personalized medicine for non–small cell lung cancer, Discov Med, 8, 227 Pao, 2010, Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer, Nat Rev Cancer, 10, 760, 10.1038/nrc2947 Sato, 2006, Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells, Cancer Res, 66, 2116, 10.1158/0008-5472.CAN-05-2521 Gazdar, 2008, Deregulated EGFR signaling during lung cancer progression: mutations, amplicons, and autocrine loops, Cancer Prev Res (Phila), 1, 156, 10.1158/1940-6207.CAPR-08-0080 Sato, 2013, Human lung epithelial cells progressed to malignancy through specific oncogenic manipulations, Mol Cancer Res, 11, 638, 10.1158/1541-7786.MCR-12-0634-T Politi, 2006, Lung adenocarcinomas induced in mice by mutant EGF receptors found in human lung cancers respond to a tyrosine kinase inhibitor or to down-regulation of the receptors, Genes Dev, 20, 1496, 10.1101/gad.1417406 Pao, 2011, Genetically informed lung cancer medicine, J Pathol, 223, 230, 10.1002/path.2788 Thu, 2012, Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability, PLoS One, 7, e33003, 10.1371/journal.pone.0033003 Wilson, 2014, EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk, Oncogene, 33, 4464, 10.1038/onc.2013.396 Chitale, 2009, An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors, Oncogene, 28, 2773, 10.1038/onc.2009.135 Chitale Coe, 2010, FACADE: a fast and sensitive algorithm for the segmentation and calling of high resolution array CGH data, Nucleic Acids Res, 38, e157, 10.1093/nar/gkq548 Ding, 2008, Somatic mutations affect key pathways in lung adenocarcinoma, Nature, 455, 1069, 10.1038/nature07423 Girard, 2016, An expression signature as an aid to the histologic classification of non–small cell lung cancer, Clin Cancer Res, 22, 4880, 10.1158/1078-0432.CCR-15-2900 Coe, 2006, Differential disruption of cell cycle pathways in small cell and non–small cell lung cancer, Br J Cancer, 94, 1927, 10.1038/sj.bjc.6603167 Lockwood, 2010, Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma, PLoS Med, 7, e1000315, 10.1371/journal.pmed.1000315 Lockwood, 2012, Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor development, PLoS One, 7, e37775, 10.1371/journal.pone.0037775 Tusher, 2001, Significance analysis of microarrays applied to the ionizing radiation response, Proc Natl Acad Sci U S A, 98, 5116, 10.1073/pnas.091062498 Lockwood, 2008, DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers, Oncogene, 27, 4615, 10.1038/onc.2008.98 Morpheus 2014, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 511, 543, 10.1038/nature13385 Cerami, 2012, The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data, Cancer Discov, 2, 401, 10.1158/2159-8290.CD-12-0095 Somwar, 2011, Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines, Proc Natl Acad Sci U S A, 108, 16375, 10.1073/pnas.1113554108 Pikor, 2013, YEATS4 is a novel oncogene amplified in non-small cell lung cancer that regulates the p53 pathway, Cancer Res, 73, 7301, 10.1158/0008-5472.CAN-13-1897 Lockwood, 2012, Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins, Proc Natl Acad Sci U S A, 109, 19408, 10.1073/pnas.1216363109 Soh, 2009, Oncogene mutations, copy number gains and mutant allele specific imbalance (MASI) frequently occur together in tumor cells, PLoS One, 4, e7464, 10.1371/journal.pone.0007464 Liao, 2017, A genetic interaction analysis identifies cancer drivers that modify EGFR dependency, Genes Dev, 31, 184, 10.1101/gad.291948.116 Taguchi, 2011, Lung cancer signatures in plasma based on proteome profiling of mouse tumor models, Cancer Cell, 20, 289, 10.1016/j.ccr.2011.08.007 Masoumi-Moghaddam, 2014, The developing story of Sprouty and cancer, Cancer Metastasis Rev, 33, 695, 10.1007/s10555-014-9497-1 Chou, 2010, EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF, Cancer Res, 70, 8822, 10.1158/0008-5472.CAN-10-0638 Ramnarain, 2006, Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells, Cancer Res, 66, 867, 10.1158/0008-5472.CAN-05-2753 Scott, 2004, GGA proteins bind ubiquitin to facilitate sorting at the trans-Golgi network, Nat Cell Biol, 6, 252, 10.1038/ncb1107 Parachoniak, 2011, GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration, Dev Cell, 20, 751, 10.1016/j.devcel.2011.05.007 Wong, 2003, Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers, Cancer, 97, 1263, 10.1002/cncr.11183 Karlsson, 2014, Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history, Clin Cancer Res, 20, 4912, 10.1158/1078-0432.CCR-14-0246 Job, 2010, Genomic aberrations in lung adenocarcinoma in never smokers, PLoS One, 5, e15145, 10.1371/journal.pone.0015145 Avraham, 2011, Feedback regulation of EGFR signalling: decision making by early and delayed loops, Nat Rev Mol Cell Biol, 12, 104, 10.1038/nrm3048 Tomas, 2014, EGF receptor trafficking: consequences for signaling and cancer, Trends Cell Biol, 24, 26, 10.1016/j.tcb.2013.11.002 Bonifacino, 2004, The GGA proteins: adaptors on the move, Nat Rev Mol Cell Biol, 5, 23, 10.1038/nrm1279 Nielsen, 2001, The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein, EMBO J, 20, 2180, 10.1093/emboj/20.9.2180 Doray, 2002, Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network, Science, 297, 1700, 10.1126/science.1075327 He, 2002, Memapsin 2 (beta-secretase) cytosolic domain binds to the VHS domains of GGA1 and GGA2: implications on the endocytosis mechanism of memapsin 2, FEBS Lett, 524, 183, 10.1016/S0014-5793(02)03052-1 del Castillo, 2010, Consortin, a trans-Golgi network cargo receptor for the plasma membrane targeting and recycling of connexins, Hum Mol Genet, 19, 262, 10.1093/hmg/ddp490 Zhang, 2016, Regulation of alpha2B-Adrenergic Receptor Cell Surface Transport by GGA1 and GGA2, Sci Rep, 6, 37921, 10.1038/srep37921 Uemura, 2018, GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth, Sci Rep, 8, 1368, 10.1038/s41598-018-19542-4